Table 3.

Pre- and post-treatment risk probabilities for participants in all treatment scenario conditions (%)

	Pre-treatment and post-treatment risks of developing the target illness							Net reduction in cancer risk
Control (C)	Mixed gain (MXG and MXG+S)		Multiple gain (MG and MG+S)		Multiple loss (ML and ML+S)
	Target risk	Harmful side effect	Target risk	Beneficial side effect	Target risk	Harmful side effect A	Harmful side effect B
25 to 10	23 to 4	2 to 6	19 to 8	6 to 2	23 to 4	1 to 3	1 to 3	15
44 to 29	42 to 23	2 to 6	38 to 27	6 to 2	42 to 23	1 to 3	1 to 3	15